Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

166.64 +4.06 (+2.50%)
Streaming Delayed Price Updated: 1:51 PM EDT, May 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
4 Analysts Have This to Say About Zoetis
Analysts have provided the following ratings for Zoetis (NYSE:ZTS) within the last quarter: 
Via Benzinga
Tesla to $1,175? Here Are 5 Other Price Target Changes for Thursday
Mizuho raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,150 to $1,175. However, Mizuho analyst Vijay Rakesh maintained a Buy rating on the stock. Tesla shares rose 3.3% to $766.88 in pre-market... 
Via Benzinga
$1000 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 13.96% on an annualized basis producing an average annual return of 23.78%. Currently, Zoetis has a market capitalization of... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
CNBC's Final Trades: Meta Platforms, Zoetis And This Stock Ahead Of Earnings
On CNBC’s “Halftime Report Final Trades,” Shannon Saccocia of Boston Private said she’s going with Meta Platforms Inc (NASDAQ: META), formerly known as Facebook. 
Via Benzinga
Zoetis Delivers First-Quarter Beat, But Guidance Takes An Unexpected Hit
Zoetis posted a strong earnings number Thursday, but the guidance haircut was unexpected. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
Upgrades 
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 5 Years
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 13.08% on an annualized basis producing an average annual return of 22.15%. Currently, Zoetis has a market capitalization of... 
Via Benzinga
Zoetis to Host Webcast and Conference Call on Second Quarter 2022 Financial Results
From Zoetis Inc.
Via Business Wire
CNBC's Final Trades: ChargePoint Holdings, Energy Puts, And These Pharma And Health Care Stocks To Buy
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is a pharma company “without all the problems 
Via Benzinga
Hot Stocks: 10 Tickers Moved By Traders on 'Fast Money Halftime Report'
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned.... 
Via Benzinga
Zoetis Completes Acquisition of Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions
From Zoetis Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! We're back with a breakdown of the biggest pre-market stock movers for Tuesday to get the day started! 
Via InvestorPlace
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 11.89% on an annualized basis producing an average annual return of 20.56%. Currently, Zoetis has a market capitalization of... 
Via Benzinga
Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
Zoetis Releases 2021 Sustainability Update to Share Progress in Championing Healthier Communities, Animals and the Planet
From Zoetis Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows. 
Via Benzinga
Zoetis Announces Agreement to Acquire Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions
From Zoetis Inc.
Via Business Wire
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 5 Years
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 10.79% on an annualized basis producing an average annual return of 21.83%. Currently, Zoetis has a market capitalization of... 
Via Benzinga
CNBC's Final Trades: Costco Wholesale, Zoetis, BlackBerry, Walt Disney And This Energy Stock
On CNBC’s “Halftime Report Final Trades,” Richard Saperstein of HighTower Treasury Partners said he loved Costco Wholesale Corporation (NASDAQ: COST). 
Via Benzinga
14 Stocks Moved By Traders On 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The... 
Via Benzinga
Zoetis to Participate in the Stifel 2022 Jaws and Paws Conference
From Zoetis Inc.
Via Business Wire
Zoetis Earnings Perspective: Return On Invested Capital
According to Benzinga Pro, during Q1, Zoetis (NYSE:ZTS) earned $594.00 million, a 43.83% increase from the preceding quarter. Zoetis also posted a total of $1.99 billion in sales, a 0.97% increase... 
Via Benzinga
Zoetis Declares Third Quarter 2022 Dividend
From Zoetis Inc.
Via Business Wire
7 Defensive Dividend Healthcare Stocks to Buy Now
As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. 
Via InvestorPlace
Zoetis: Q1 Earnings Insights
Zoetis (NYSE:ZTS) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Zoetis beat estimated earnings by 7.32%,... 
Via Benzinga
Zoetis Announces First Quarter 2022 Results
From Zoetis Inc.
Via Business Wire
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. 
Via Benzinga
CNBC's Final Trades: Zoetis, VanEck Gold Miners ETF, Paramount Global And This Energy Stock
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is “the largest provider of vaccines and medicines for pets and live 
Via Benzinga
Why Stephanie Link Is Watching Starbucks And This Stock Down Nearly 30% YTD
Hightower Advisors' Stephanie Link believes we are still in the midst of a bull market. Accordingly, she has identified a couple of stocks well off their highs that she would like to buy on any further... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.